Charterhouse backs Belgian pharmaceuticals business SERB
Charterhouse Capital Partners has acquired a majority stake in Belgian pharmaceuticals business SERB.
The deal represents the fourth acquisition for the firm’s tenth fund, which closed
Charterhouse Capital Partners has acquired a majority stake in Belgian pharmaceuticals business SERB.
The deal represents the fourth acquisition for the firm’s tenth fund, which closed